Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
SURMOUNT-5 Trial Overview SURMOUNT-5 (NCT05822830) is a multicenter, randomized, open-label Phase 3b trial aimed at assessing the efficacy and safety of Zepbound (tirzepatide) compared to Wegovy (semaglutide) in adults with obesity or overweight, with at least one comorbidity (such as hypertension, dyslipidemia, obstructive sleep apnea (OSA), or cardiovascular disease), and no diabetes
Patients are encouraged to consult with their healthcare provider if symptoms persist or worsen
All products are manufactured in Korea
If you feel your concerns are not being adequately addressed, you have the right to request a second opinion or referral to a specialist diabetes service
US$ 28.86
US$ 25.87
US$ 21.14
US$ 24.39
:max_bytes(150000):strip_icc()/Smoothie-King-Launches-GLP-1-Menu-FT-BLOG1024-f58e53e922864e37b5ea2ad4ae7abd2d.jpg)
